Actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer (vol 9, pg 1061, 2019)
第一作者单位:[1]Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Clin Res Ctr, Beijing 100045, Peoples R China[2]Peking Univ, Sch Pharmaceut Sci, Key Lab Mol Pharmaceut, New Drug Delivery Syst, Beijing 100191, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
Mei Dong,Chen Binlong,He Bing,et al.Actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer (vol 9, pg 1061, 2019)[J].ACTA PHARMACEUTICA SINICA B.2020,10(6):1143-1144.doi:10.1016/j.apsb.2020.03.003.
APA:
Mei, Dong,Chen, Binlong,He, Bing,Liu, Haibin,Lin, Zhiqiang...&Zhang, Qiang.(2020).Actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer (vol 9, pg 1061, 2019).ACTA PHARMACEUTICA SINICA B,10,(6)
MLA:
Mei, Dong,et al."Actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer (vol 9, pg 1061, 2019)".ACTA PHARMACEUTICA SINICA B 10..6(2020):1143-1144